(1)
Byrd, K.; Truong, P. Bortezomib in the Treatment of Acquired Von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance.
kjm
2014
,
7
(4), 167-170.
https://doi.org/10.17161/kjm.v7i4.11507
.